Abrdn Healthcare Investors (HQH) Stock Analysis & Winston Score
Abrdn Healthcare Investors is a closed-end investment fund that pools money from investors and uses it to buy stocks and other securities in the healthcare industry. Its portfolio focuses on companies in areas like biotechnology, pharmaceuticals, medical devices, and healthcare services. The fund is managed by abrdn, a global asset management firm, and trades on the New York Stock Exchange under the ticker HQH. The fund makes money by earning returns on its investments — through dividends, interest, and capital gains — and charges investors a management fee based on assets under management. It primarily invests in U.S. healthcare companies, though it may hold some international positions. Because it is a closed-end fund, its share price can trade at a discount or premium to the actual value of its holdings, which is a key risk for investors. The main growth driver is performance in the healthcare sector, while rising interest rates and biotech volatility remain the biggest ongoing risks.
Winston Score: 56/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Strong (25/30)
- Growth: Good (12/20)
- Cash Flow: Mixed (4/10)
- Stability: Good (5/10)
- Valuation: Good (6/10)
- Ownership: Weak (1/15)
Key Facts
Price: $20.88
Market Cap: $1.2B
Sector: Financial Services
Industry: Asset Management
Exchange: New York Stock Exchange


